Key result
Continuous intracoronary injection of highly oxygenated autologous blood successfully restored TIMI III flow and stabilized hemodynamics in a patient with refractory no-reflow during primary PCI.
Why the study?
Slow-flow and no-reflow cause sudden loss of coronary flow during primary PCI, prompting reports of alternative techniques to conventional therapy.
Does autologous blood injection intracoronary artery improve coronary flow in a patient with slow-flow and no-reflow during primary PCI for ACS?
Case Report (n=1)
No
Does autologous blood injection intracoronary artery improve coronary flow in a patient with slow-flow and no-reflow during primary PCI for ACS?
Intracoronary injection of autologous blood combined with active balloon angioplasty successfully restored TIMI III flow in a patient with refractory no-reflow during primary PCI for ACS.
Answers are grounded in this paper and cite their sources.
May aid refractory no-reflow during PCI; leaves open confirmation in prospective trials.
Slow-flow and no-reflow phenomenon are taken to sudden loss of coronary artery flow, typically after stenting or angioplasty in primary PCI. Otherwise conventional therapy, we report a technique, which autologous blood into intracoronary to supply oxygen and break process thrombosis results in successfully management no-reflow in primary PCI in ACS.
No takes yet. Share an insight, caveat, or question.
Hoai et al. (2022) conducted a case report in Acute coronary syndrome with slow-flow/no-reflow during primary PCI (n=1). Autologous blood injection intracoronary artery was evaluated on Restoration of coronary flow (TIMI flow). Continuous intracoronary injection of highly oxygenated autologous blood successfully restored TIMI III flow and stabilized hemodynamics in a patient with refractory no-reflow during primary PCI.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: